Search Results - "Pezawas, L"

Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression by Pezawas, L, Meyer-Lindenberg, A, Goldman, A L, Verchinski, B A, Chen, G, Kolachana, B S, Egan, M F, Mattay, V S, Hariri, A R, Weinberger, D R

“…Complex genetic disorders such as depression likely exhibit epistasis, but neural mechanisms of such gene–gene interactions are incompletely understood…”
Get full text

Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia by Sauerzopf, U., Weidenauer, A., Dajic, I., Bauer, M., Bartova, L., Meyer, B., Nics, L., Philippe, C., Pfaff, S., Pichler, V., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Lanzenberger, R., Pezawas, L., Praschak-Rieder, N., Willeit, M.

“…•Disturbed glycemic control is an intrinsic feature of schizophrenia.•The neurotransmitter dopamine has a key role in regulating glucose homeostasis.•We…”
Get full text

S.28.04 Serotonin transporter gene polymorphism and susceptibility to depression by Pezawas, L

Get full text

Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders by Spindelegger, C, Lanzenberger, R, Wadsak, W, Mien, L K, Stein, P, Mitterhauser, M, Moser, U, Holik, A, Pezawas, L, Kletter, K, Kasper, S

“…There is an increasing interest in the underlying mechanisms of the antidepressant and anxiolytic treatment effect associated with changes in serotonergic…”
Get full text

Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders by Spindelegger, C, Lanzenberger, R, Wadsak, W, Mien, L K, Stein, P, Mitterhauser, M, Moser, U, Holik, A, Pezawas, L, Kletter, K, Kasper, S

“…There is an increasing interest in the underlying mechanisms of the antidepressant and anxiolytic treatment effect associated with changes in serotonergic…”
Get full text

Effects of antidepressant treatment with escitalopram on hippocampal structure and connectivity − a longitudinal study by Rabl, U, Provenzano, J, Meyer, B.M, Bartova, L, Ortner, N, Sezen, P, Moser, E, Kasper, S, Pezawas, L

Get full text

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis by Bagnato, F, Butman, J.A, Gupta, S, Calabrese, M, Pezawas, L, Ohayon, J.M, Tovar-Moll, F, Riva, M, Cao, M.M, Talagala, S.L, McFarland, H.F

“…In vivo detection of cortical lesions in patients with multiple sclerosis (MS) by MR imaging is hampered by several factors. Among them is the low contrast…”
Get full text

Additive Gene-Environment Effects on Hippocampal Structure in Healthy Humans by Rabl, U., Meyer, B. M., Diers, K., Bartova, L., Berger, A., Mandorfer, D., Popovic, A., Scharinger, C., Huemer, J., Kalcher, K., Pail, G., Haslacher, H., Perkmann, T., Windischberger, C., Brocke, B., Sitte, H. H., Pollak, D. D., Dreher, J.-C., Kasper, S., Praschak-Rieder, N., Moser, E., Esterbauer, H., Pezawas, L.

Get full text

The dependence on noise and inter-subject variability of different group analysis methods in dynamic causal modeling by Kasess, C.H., Weissenbacher, A., Pezawas, L., Moser, E., Windischberger, C.

“…On a group level, however, several approaches exist: (a) random effects (RFX) second level analysis based only on the mean parameter estimates (b) a more…”
Get full text

Buprenorphine versus methadone maintenance for the treatment of opioid dependence by Fischer, Gabriele, Gombas, Wolfgang, Eder, Harald, Jagsch, Reinhold, Peternell, Alexandra, Stuhlinger, Georg, Pezawas, Lukas, Aschauer, Harald N., Kasper, Siegfried

“…Aims. To evaluate the effectiveness of buprenorphine compared with methadone maintenance therapy in opiate addicts over a treatment period of 24 weeks. Design…”
Get full text

P.1.033 Serotonin uptake in platelets predicts neural activation in the cingulate cortex by Scharinger, C, Kasess, C, Huf, W, Kalcher, K, Esterbauer, H, Moser, E, Sitte, H.H, Kasper, S, Pezawas, L

Get full text

P.2.c.020 Synthesising evidence in clinical psychopharmacology and beyond: a re-examination of published meta-analyses by Huf, W, Kalcher, K, Pail, G, Boubela, R, Pezawas, L, Windischberger, C, Moser, E, Friedrich, M.E, Filzmoser, P, Kasper, S

Get full text

S.07.04 Alterations of functional connectivity between basal ganglia and cortical regions during resting-state in remitted major depressive disorder by Kalcher, K, Pail, G, Huf, W, Scharinger, C, Boubela, R, Windischberger, C, Filzmoser, P, Moser, E, Kasper, S, Pezawas, L

Get full text

P.3.016 Increased functional coupling between basal ganglia and cortical regions during resting state in remitted major depressive disorder by Kalcher, K, Pail, G, Huf, W, Scharinger, C, Boubela, R, Windischberger, C, Filzmoser, P, Moser, E, Kasper, S, Pezawas, L

Get full text

P02-89 - Peripheral serotonin uptake is related to neural activation in the cingulate cortex by Scharinger, C, Kasess, C, Huf, W, Kalcher, K, Esterbauer, H, Sitte, H, Kasper, S, Moser, E, Pezawas, L

“…Introduction Maximal serotonin transporter (5-HTT) densities have been found in the cingulate cortex, a cortical region that has been critically implicated in…”
Get full text

Parsing the clinical phenotype of depression: the need to integrate brief depressive episodes by Angst, J., Gamma, A., Pezawas, L., Ajdacic-Gross, V., Eich, D., Rössler, W., Altamura, C.

“…Objective:  To expand the concept of recurrent brief depression (RBD) to brief depression (BD) and to test its clinical relevance. Method:  Subjects (N = 591)…”
Get full text

P.2.b.025 Serotonin uptake in blood platelets is related to cingulate cortex activation by Kasess, C, Scharinger, C, Pail, G, Uzelac, Z, Freissmuth, M, Kasper, S, Moser, E, Sitte, H, Pezawas, L

Get full text

P02-319 - Increased functional coupling between basalganglia and cingulate and prefrontal cortex during resting state conditions in remitted major depressive disorder by Boubela, R, Kalcher, K, Pail, G, Huf, W, Scharinger, C, Hartinger, B, Windischberger, C, Filzmoser, P, Moser, E, Kasper, S, Pezawas, L

“…Introduction Converging evidence suggests alterations of neural activation in the basal ganglia to represent neural correlates of Major Depressive Disorder…”
Get full text

P02-38 - Biological alterations during remission of major depressive disorder by Hartinger, B, Scharinger, C, Diers, K, Kasess, C, Huf, W, Kalcher, K, Boubela, R, Pail, G, Brocke, B, Kasper, S, Moser, E, Pezawas, L

“…Introduction The natural course of Major Depressive Disorder (MDD) encompasses the occurrence of alternating intervals of major depressive episodes and…”
Get full text

P02-352 - Remitted major depression is related to increased functional coupling between ventral striatum and cortical regions in resting state fMRI by Pail, G, Scharinger, C, Kalcher, K, Huf, W, Boubela, R, Hartinger, B, Windischberger, C, Filzmoser, P, Moser, E, Kasper, S, Pezawas, L

“…Introduction Dysfunction in the basal ganglia has been related to impaired reward processing and anhedonia, a core symptom of Major Depressive Disorder (MDD)…”
Get full text